Archive for January, 2009

Drug Store News - Watson’s generic Vasotec gets OK

Thursday, January 8th, 2009

The FDA has tentatively approved Watson’s abbreviated new drug application for Enalapril Maleate tablets, 2.5 mg, 5 mg, 10 mg, and 20 mg. Enalapril Maleate is the generic equivalent of Merck’s ACE-inhibitor Vasotec. Watson said final approval of the…

Drug Store News - Odyssey launches generic Urecholine

Saturday, January 3rd, 2009

Odyssey Pharmaceuticals is marketing 5 mg, 10 mg and 50 mg tablets of bethanechol, the generic version of Merck’s Urecholine. The drug treats bladder obstructions. Three other Merck products: hypertension drug Vasotec (enalapril maleate), Pepcid (famotidine) for ulcers and Mevacor (lovastatin) for cholesterol likely will lose patent …